CY1105947T1 - Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων - Google Patents

Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων

Info

Publication number
CY1105947T1
CY1105947T1 CY20071100089T CY071100089T CY1105947T1 CY 1105947 T1 CY1105947 T1 CY 1105947T1 CY 20071100089 T CY20071100089 T CY 20071100089T CY 071100089 T CY071100089 T CY 071100089T CY 1105947 T1 CY1105947 T1 CY 1105947T1
Authority
CY
Cyprus
Prior art keywords
nucleic acids
proteins
mycoplasma hyopneumoniae
gene nucleic
mhp3 gene
Prior art date
Application number
CY20071100089T
Other languages
English (en)
Inventor
Kendall Wayne King
Rebecca Anne Madura
Everett Lee Rosey
Original Assignee
Pfizer Products Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Incorporated filed Critical Pfizer Products Incorporated
Publication of CY1105947T1 publication Critical patent/CY1105947T1/el

Links

Classifications

    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K37/00—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors
    • H02K37/10—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors of permanent magnet type
    • H02K37/12—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors of permanent magnet type with stationary armatures and rotating magnets
    • H02K37/14—Motors with rotor rotating step by step and without interrupter or commutator driven by the rotor, e.g. stepping motors of permanent magnet type with stationary armatures and rotating magnets with magnets rotating within the armatures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Power Engineering (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε νουκλεϊνικά οξέα του mhp3 και σε πρωτεΐνες που κωδικοποιούνται από αυτά. Η παρούσα εφεύρεση αφορά επιπλέον σε νεοφανή αντιγόνα αποπρωτεΐνης που κωδικοποιούνται από το mhp3 για χρήση σε εμβόλια προκειμένου να γίνει πρόληψη και θεραπεία νοσημάτων που προκαλούνται από μόλυνση από το Mycoplasma hyopneymoniae. Η εφεύρεση αφορά επιπλέον σε μεθόδους για την ανασυνδυασμένη παραγωγή τέτοιου τύπου αντιγόνων.
CY20071100089T 2001-03-28 2007-01-25 Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων CY1105947T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002340455A CA2340455A1 (en) 2001-03-28 2001-03-28 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
EP01303030A EP1245677B1 (en) 2001-03-28 2001-03-30 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
JP2001101364A JP2002306169A (ja) 2001-03-28 2001-03-30 マイコプラズマ属のＭｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅのｍｈｐ３遺伝子の核酸およびタンパク質ならびにそれらの使用

Publications (1)

Publication Number Publication Date
CY1105947T1 true CY1105947T1 (el) 2011-04-06

Family

ID=27171482

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100089T CY1105947T1 (el) 2001-03-28 2007-01-25 Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων

Country Status (8)

Country Link
EP (1) EP1245677B1 (el)
JP (1) JP2002306169A (el)
AT (1) ATE349530T1 (el)
CA (1) CA2340455A1 (el)
CY (1) CY1105947T1 (el)
DE (1) DE60125507T2 (el)
DK (1) DK1245677T3 (el)
ES (1) ES2277893T3 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2694511T3 (es) 2009-12-04 2018-12-21 Lsi Medience Corporation Procedimiento de detección de microorganismos pertenecientes a Mycoplasma pneumoniae y/o Mycoplasma genitalium
CN105792841B (zh) * 2013-11-21 2019-07-26 财团法人农业科技研究院 防治霉浆菌感染的组合物
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
CN106928373B (zh) * 2017-03-17 2020-08-28 青岛明勤生物科技有限公司 一种猪支原体肺炎多表位黏膜疫苗
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof

Also Published As

Publication number Publication date
CA2340455A1 (en) 2002-09-28
EP1245677B1 (en) 2006-12-27
DE60125507T2 (de) 2007-10-04
ATE349530T1 (de) 2007-01-15
ES2277893T3 (es) 2007-08-01
EP1245677A1 (en) 2002-10-02
DE60125507D1 (de) 2007-02-08
JP2002306169A (ja) 2002-10-22
DK1245677T3 (da) 2007-04-02

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
CY1105685T1 (el) Συνδεομενα με ογκους αντιγονικα παραγωγα απο την οικογενεια mage, και ακολουθιες νουκλεϊκων οξεων που τα κωδικοποιουν, χρησιμοποιουμενα στην παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο
ATA1302001A (de) Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
ATE365749T1 (de) Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken
CY1114265T1 (el) Πρωτεϊνη συντηξης αλβουμινης
DE60230029D1 (de) Immunisierungstherapie zur behandlung von atherosklerose
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
CY1110533T1 (el) Μεθοδοι και σκευασματα για νοσους σχετιζομενες με την αμυλοειδωση
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DK1487485T3 (da) Imidazoquinolinadjuvanser til DNA-vacciner
FR2827866B1 (fr) Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
DE60229659D1 (de) Antigen-raster enthaltend rankl zur behandlung von knochenerkrankungen
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
DE60335726D1 (de) Chromoprotein und fluoroproteine
CY1107784T1 (el) Πρωτεϊνη συντηξης g του ihnv για διεγερση του ανοσοποιητικου συστηματος
BR0208786A (pt) Métodod para identificação de proteìnas de bactérias intracelulares
EP1090995A3 (en) Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
DE60208534D1 (de) Verwendung von antikörper gegen mag zur behandlung ischämischer schlaganfälle
HUP0104519A2 (hu) Eljárások antigén-szekvenciák azonosítására
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
MX2020009507A (es) Anticuerpos de dominio individual que se unen a la neurotoxina del tetanos.